Dow Up 0.36% Nasdaq Up 0.12%

Cyclacel Pharmaceuticals, Inc. (CYCC)

-NasdaqGM
3.13 0.04(1.26%) Aug 21, 4:00PM EDT
Prev Close:3.17
Open:3.16
Bid:N/A
Ask:3.69 x 100
1y Target Est:9.67
Beta:2.4
Next Earnings Date:N/A
Day's Range:3.11 - 3.24
52wk Range:2.78 - 5.50
Volume:29,814
Avg Vol (3m):115,416
Market Cap:70.98M
P/E (ttm):N/A
EPS (ttm):-0.73
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYCC

Comparison

Symbol% ChgMkt Cap
CYCCDown 1.26%70.98M
AZN92.44B
JNJ291.87B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):56.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.01
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback